Insider filing · VRTX

Jeffrey M Leiden sold $32.3M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Nov 13 2025, disclosed Nov 17 2025, 4 days later.

Returns are measured on stock purchases only.

JL Jeffrey M Leiden Executive Chairman profile →

Jeffrey M Leiden (Executive Chairman) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). Across 1 priced purchase filing, the average 21-session return was -14.4% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $32.3M of VRTX (73,252 sh across 4 lots, as filed), executed Nov 13 2025.

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→